Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
58%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
88%
ALSO IN IBB
IBB
258
HOLDINGS
10%
ALSO IN BBH
SECTOR DRIFT (BBH minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 13.4% | 7.7% | 7.7% |
|
VERTEX PHARMACEUTICALS INC | 10.5% | 7.7% | 7.7% |
|
AMGEN INC | 15.7% | 7.4% | 7.4% |
|
REGENERON PHARMACEUTICALS | 5.1% | 6.4% | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 4.9% | 4.7% | 4.7% |
BBH Overweight Relative to IBB
|
AMGEN INC | 8.3% |
|
GILEAD SCIENCES INC | 5.6% |
 |
ICON PLC | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
 |
ARGENX SE ADR | 2.4% |
|
NATERA INC | 2.0% |
|
QIAGEN NV | 1.7% |
|
EXACT SCIENCES CORP | 1.6% |
|
INSMED INC | 1.5% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% |
BBH Underweight Relative to IBB
 |
METTLER-TOLEDO INTERNATIONAL | -2.9% |
|
WATERS CORP | -2.5% |
|
UNITED THERAPEUTICS CORP | -1.5% |
|
EXELIXIS INC | -1.4% |
|
REGENERON PHARMACEUTICALS | -1.3% |
 |
GENMAB A/S SPONSORED ADR | -1.0% |
|
BLUEPRINT MEDICINES CORP. | -0.9% |
|
MEDPACE HOLDINGS, INC. | -0.9% |
|
BRIDGEBIO PHARMA, INC. | -0.8% |
|
ASCENDIS PHARMA A/S | -0.8% |